BSND
Basic information
Region (hg38): 1:54998933-55017172
Previous symbols: [ "DFNB73" ]
Links
Phenotypes
GenCC
Source:
- Bartter disease type 4A (Strong), mode of inheritance: AR
- Bartter disease type 4A (Definitive), mode of inheritance: AR
- Bartter syndrome type 4 (Supportive), mode of inheritance: AR
- hearing loss, autosomal recessive (Supportive), mode of inheritance: AR
- Bartter disease type 4A (Strong), mode of inheritance: AR
- Bartter disease type 4A (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Bartter syndrome, type 4A, neonatal, with sensorineural deafness | AR | Audiologic/Otolaryngologic; Renal | Individuals may have renal perturbations, (eg, including metabolic alkalosis and hypokalemia), for which treatment can be beneficial; Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic; Renal | 11687798; 12574213; 19646679; 21158220; 21269598; 23110775; 30174009; 31667618 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (287 variants)
- Bartter_syndrome (72 variants)
- Bartter_disease_type_4A (70 variants)
- Inborn_genetic_diseases (43 variants)
- not_specified (42 variants)
- BSND-related_disorder (9 variants)
- Sensorineural_deafness_with_mild_renal_dysfunction (2 variants)
- Hearing_loss,_autosomal_recessive (2 variants)
- Hearing_impairment (2 variants)
- Bartter_syndrome_type_4 (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BSND gene is commonly pathogenic or not. These statistics are base on transcript: NM_000057176.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 145 | 151 | ||||
missense | 105 | 16 | 130 | |||
nonsense | 14 | |||||
start loss | 1 | 1 | 1 | 3 | ||
frameshift | 15 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
Total | 21 | 15 | 116 | 163 | 3 |
Highest pathogenic variant AF is 0.000189723
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BSND | protein_coding | protein_coding | ENST00000371265 | 4 | 11951 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.09e-10 | 0.0256 | 125660 | 0 | 88 | 125748 | 0.000350 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0663 | 190 | 193 | 0.987 | 0.0000112 | 2125 |
Missense in Polyphen | 72 | 70.195 | 1.0257 | 796 | ||
Synonymous | -1.42 | 96 | 79.8 | 1.20 | 0.00000501 | 615 |
Loss of Function | -0.605 | 14 | 11.8 | 1.19 | 5.06e-7 | 129 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00227 | 0.00227 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000927 | 0.0000924 |
European (Non-Finnish) | 0.000221 | 0.000220 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000490 | 0.000490 |
Other | 0.000332 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a beta-subunit for CLCNKA and CLCNKB chloride channels. In the kidney CLCNK/BSND heteromers mediate chloride reabsorption by facilitating its basolateral efflux. In the stria, CLCNK/BSND channels drive potassium secretion by recycling chloride for the basolateral SLC12A2 cotransporter. {ECO:0000269|PubMed:11734858, ECO:0000269|PubMed:12111250}.;
- Disease
- DISEASE: Bartter syndrome 4A, neonatal, with sensorineural deafness (BARTS4A) [MIM:602522]: A form of Bartter syndrome, an autosomal recessive disorder characterized by impaired salt reabsorption in the thick ascending loop of Henle with pronounced salt wasting, hypokalemic metabolic alkalosis, and varying degrees of hypercalciuria. BARTS4A is associated with sensorineural deafness. {ECO:0000269|PubMed:11687798, ECO:0000269|PubMed:12111250, ECO:0000269|PubMed:12574213, ECO:0000269|PubMed:12761627}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Diuretics Pathway, Pharmacodynamics;Stimuli-sensing channels;Ion channel transport;Transport of small molecules
(Consensus)
Recessive Scores
- pRec
- 0.365
Intolerance Scores
- loftool
- 0.323
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.16
Haploinsufficiency Scores
- pHI
- 0.0748
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.467
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0856
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bsnd
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- ion transmembrane transport;chloride transmembrane transport
- Cellular component
- cytoplasm;plasma membrane;integral component of plasma membrane;basolateral plasma membrane;protein-containing complex
- Molecular function
- voltage-gated chloride channel activity;chloride channel activity;chloride channel regulator activity